Exacerbations in Patients with Chronic Obstructive Pulmonary Disease Treated with Nebulized Glycopyrrolate versus Other Long-Acting Muscarinic Antagonists: A U.S. Healthcare Administrative Database Analysis
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.